Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Silver

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
Menopause (New York, N.Y.)|October 26, 2018
Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophyRebecca M Brotman, Michelle D Shardell, Pawel Gajer, et al.
Surgical Endoscopy|May 5, 1999
Measurement of urinary N-acetyl-beta-D-glucosaminidase to assess renal ischemia during laparoscopic operationsS Micali, R I Silver, H S Kaufman, et al.
O&G Open|September 26, 2025
Accessibility of Criteria to Exit Cervical Cancer Screening at Age 65 Years in the Electronic Health RecordStephanie Alimena, Jacquelyn M Lykken, Jasmin A Tiro, et al.
Preventive Medicine Reports|June 26, 2023
Factors associated with shorter-interval cervical cancer screening for young women in three United States healthcare systemsAnne Marie McCarthy, Jasmin A Tiro, Ellen Hu, et al.
JAMA Network Open|February 26, 2026
A Multicomponent Strategy to Increase Human Papillomavirus Vaccination Rates in Primary Care: A Cluster Randomized Clinical TrialRuoyun Wang, Lei Liu, Sherry Dodd, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 2, 2022
Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment IntervalJessica Chubak, Andrea N Burnett-Hartman, William E Barlow, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 23, 2024
Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare SettingsDavid Cheng, Meghan L Rieu-Werden, Jacquelyn M Lykken, et al.
Preventive Medicine|November 11, 2021
Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristicsJennifer S Haas, David Cheng, Liyang Yu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 14, 2018
Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21-39 YearsMichelle I Silver, Julia C Gage, Mark Schiffman, et al.
Journal of Translational Medicine|February 7, 2026
Spatial resolution of the metastatic osteosarcoma tumor microenvironment using immunolabeling across murine, canine and human lungBeck J A, J S Pereira, K I Silver, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
Menopause (New York, N.Y.)|October 26, 2018
Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophyRebecca M Brotman, Michelle D Shardell, Pawel Gajer, et al.
Surgical Endoscopy|May 5, 1999
Measurement of urinary N-acetyl-beta-D-glucosaminidase to assess renal ischemia during laparoscopic operationsS Micali, R I Silver, H S Kaufman, et al.
O&G Open|September 26, 2025
Accessibility of Criteria to Exit Cervical Cancer Screening at Age 65 Years in the Electronic Health RecordStephanie Alimena, Jacquelyn M Lykken, Jasmin A Tiro, et al.
Preventive Medicine Reports|June 26, 2023
Factors associated with shorter-interval cervical cancer screening for young women in three United States healthcare systemsAnne Marie McCarthy, Jasmin A Tiro, Ellen Hu, et al.
JAMA Network Open|February 26, 2026
A Multicomponent Strategy to Increase Human Papillomavirus Vaccination Rates in Primary Care: A Cluster Randomized Clinical TrialRuoyun Wang, Lei Liu, Sherry Dodd, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 2, 2022
Estimating Cancer Screening Sensitivity and Specificity Using Healthcare Utilization Data: Defining the Accuracy Assessment IntervalJessica Chubak, Andrea N Burnett-Hartman, William E Barlow, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 23, 2024
Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare SettingsDavid Cheng, Meghan L Rieu-Werden, Jacquelyn M Lykken, et al.
Preventive Medicine|November 11, 2021
Variation in the receipt of human papilloma virus co-testing for cervical screening: Individual, provider, facility and healthcare system characteristicsJennifer S Haas, David Cheng, Liyang Yu, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 14, 2018
Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21-39 YearsMichelle I Silver, Julia C Gage, Mark Schiffman, et al.
Journal of Translational Medicine|February 7, 2026
Spatial resolution of the metastatic osteosarcoma tumor microenvironment using immunolabeling across murine, canine and human lungBeck J A, J S Pereira, K I Silver, et al.
Pageof 13